Literature DB >> 11033133

Long-term outcome after radiation therapy for subfoveal choroidal neovascularization associated with age-related macular degeneration.

M Mandai1, M Takahashi, H Miyamoto, N Hiroshiba, H Kimura, Y Ogura, Y Honda, K Sasai.   

Abstract

PURPOSE: The purpose of this study was to investigate the long-term effect of low-dose radiation therapy on subfoveal choroidal neovascularization associated with age-related macular degeneration.
METHODS: The clinical course and visual outcome were compared retrospectively among two treated groups and a control group; 15 patients (15 eyes) received 10 Gy, another 15 patients (15 eyes) received 20 Gy. The control group consisted of 15 patients (15 eyes) without treatment. All patients were followed up for at least 18 months, and most were followed up for 3 years. The macula was irradiated with either 10 Gy in 5 fractions or with 20 Gy in 10 fractions after computed tomography (CT) simulation enabled real-time treatment planning from multiple CT slices.
RESULTS: During the 3 years of follow-up, the lesions became better in 5 eyes, unchanged in 1, and worse in 9 with 10 Gy radiation; better in 7 eyes, unchanged in 1, and worse in 7 eyes with 20 Gy; and better in 1 eye and worse in 14 with no treatment. The difference between the groups treated with radiation and the control was statistically significant (P <.05). Visual acuity was also significantly better in the group receiving 20 Gy than in the control group up to 2 years after radiation (P <.01).
CONCLUSION: Radiation may extend the period of good visual function substantially by reducing subfoveal choroidal neovascularization activity.

Entities:  

Mesh:

Year:  2000        PMID: 11033133     DOI: 10.1016/s0021-5155(00)00217-3

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  4 in total

1.  Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration.

Authors:  S Aisenbrey; B A Lafaut; S Reynders; P Szurman; S Grisanti; C Vanden Broecke; P Walter; K U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-22       Impact factor: 3.117

Review 2.  Radiotherapy for neovascular age-related macular degeneration.

Authors:  Jennifer R Evans; Vasuki Sivagnanavel; Victor Chong
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

3.  Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study.

Authors:  P T Finger; Y P Gelman; A M Berson; A Szechter
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

Review 4.  Tracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study.

Authors:  Mari Elshout; Carroll A Webers; Margriet I van der Reis; Yvonne de Jong-Hesse; Jan S Schouten
Journal:  BMC Ophthalmol       Date:  2017-07-11       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.